Skip to main content

Table 2 5-year rates of DMFS by sub-group

From: Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy

Sub-group Number of patients 5-year DMFS (%) 95% CI
All patients 421 87.8 84.1–91.5
2–3 Intermediate risk factors 104 93.7 88.2–99.2
1 High risk factor 225 88.0 83.1–92.9
2–3 High risk factors 92 81.2 71.6–90.8
V High Risk 126 78.4 70.8–86.0
  1. Abbreviations: CI confidence interval, DMFS distant metastases-free survival